AllianceBernstein
ARVN icon

AllianceBernstein’s Arvinas ARVN Stock Holding History

AllianceBernstein’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$676K Sell
63,820
-9,900
-13% -$92.3K ﹤0.01% 2561
2026
Q1 		$874K Hold
73,720
– – ﹤0.01% 2388
2025
Q4 		$874K Hold
73,720
– – ﹤0.01% 2398
2025
Q3 		$628K Hold
73,720
– – ﹤0.01% 2559
2025
Q2 		$543K Hold
73,720
– – ﹤0.01% 2595
2025
Q1 		$518K Hold
73,720
– – ﹤0.01% 2541
2024
Q4 		$1.41M Hold
73,720
– – ﹤0.01% 2139
2024
Q3 		$1.82M Hold
73,720
– – ﹤0.01% 2011
2024
Q2 		$1.96M Buy
73,720
+17,250
+31% +$550K ﹤0.01% 1964
2024
Q1 		$2.33M Buy
56,470
+3,970
+8% +$173K ﹤0.01% 1834
2023
Q4 		$2.16M Hold
52,500
– – ﹤0.01% 1897
2023
Q3 		$1.03M Hold
52,500
– – ﹤0.01% 2229
2023
Q2 		$1.3M Sell
52,500
-50,000
-49% -$1.29M ﹤0.01% 2138
2023
Q1 		$2.8M Sell
102,500
-33,400
-25% -$1.06M ﹤0.01% 1687
2022
Q4 		$4.65M Buy
135,900
+80,000
+143% +$3.37M ﹤0.01% 1462
2022
Q3 		$2.49M Sell
55,900
-63,885
-53% -$3.1M ﹤0.01% 1743
2022
Q2 		$5.04M Buy
119,785
+67,829
+131% +$3.4M ﹤0.01% 1449
2022
Q1 		$3.5M Buy
51,956
+356
+0.7% +$24.3K ﹤0.01% 1763
2021
Q4 		$4.24M Sell
51,600
-3,400
-6% -$277K ﹤0.01% 1705
2021
Q3 		$4.52M Buy
55,000
+200
+0.4% +$17.7K ﹤0.01% 1665
2021
Q2 		$4.22M Buy
54,800
+7,600
+16% +$528K ﹤0.01% 1732
2021
Q1 		$3.12M Buy
47,200
+500
+1% +$38.3K ﹤0.01% 1833
2020
Q4 		$3.97M Hold
46,700
– – ﹤0.01% 1625
2020
Q3 		$1.1M Sell
46,700
-600
-1% -$17.4K ﹤0.01% 2140
2020
Q2 		$1.59M Buy
47,300
+22,000
+87% +$934K ﹤0.01% 1972
2020
Q1 		$1.02M Buy
25,300
+2,400
+10% +$112K ﹤0.01% 2027
2019
Q4 		$941K Buy
22,900
+6,400
+39% +$187K ﹤0.01% 2306
2019
Q3 		$356K Buy
16,500
+3,000
+22% +$73.6K ﹤0.01% 2721
2019
Q2 		$297K Buy
+13,500
New +$284K ﹤0.01% 2830

Other funds holding ARVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein's ARVN Position: Q2 2026 in Review

AllianceBernstein reduced its Arvinas (ARVN) stake by 13% in Q2 2026, selling an estimated $92.3K and leaving 63,820 shares worth $676K. The position accounts for ﹤0.01% of the portfolio, ranked #2561.

AllianceBernstein first reported a position in ARVN in Q2 2019 and has held it in 29 quarters since. The position peaked at $5.04M in Q2 2022. 200 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

  • AllianceBernstein held 63,820 shares of Arvinas worth $676K as of Q2 2026.
  • AllianceBernstein sold 9,900 Arvinas shares in Q2 2026, an estimated $92.3K.
  • Arvinas made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2561 holding.
  • AllianceBernstein first reported a position in Arvinas in Q2 2019 and has held it in 29 quarters since.
  • AllianceBernstein's Arvinas position peaked at $5.04M in Q2 2022.
  • 200 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.